A common gut bacteria shift shows up again and again in allergic rhinitis, 640-person study finds

If your stuffy nose, itchy eyes, and sneezing fits never seem to have an obvious trigger, you have probably wondered whether something deeper than pollen is going on. A new case-control study adds a specific, numeric answer to that hunch: adults with allergic rhinitis (AR, the medical term for chronic nasal allergy symptoms) carry a measurably different population of gut bacteria than people without it, and the pattern lines up with what at least one other research group has already found.

Key takeaways:

• Adults with allergic rhinitis (n=320) had lower gut bacterial diversity and a different bacterial mix than matched healthy controls (n=320).
• Two genera stood out: Prevotella was lower in the allergy group and linked to lower allergy odds at higher levels, while Escherichia was higher in the allergy group and linked to higher allergy odds.
• A separate, independently run Japanese cohort (the Hitachi Health Study) found the same direction of association for both bacteria, which strengthens confidence in the pattern.
• This is a cross-sectional case-control study, so it shows an association, not proof that the bacteria cause the allergy symptoms.

Lower Gut Bacterial Diversity Marks Allergic Rhinitis in Adults

Adults with allergic rhinitis have a measurably less diverse gut microbiome than people without the condition, according to a case-control study published in the Journal of Animal Environment. Researchers at Saveetha Medical College and Hospital in Chennai, India, compared stool samples from 320 adults with AR to 320 matched controls and found a lower Shannon index (a standard measure of how many different species are present and how evenly balanced they are) in the allergy group: 4.28 versus 4.71 in controls. The two groups' overall bacterial makeup was also statistically distinct (PERMANOVA p = 0.015), meaning it wasn't just less diverse, it was a different community altogether.

Millions of People With Chronic Nasal Allergies Could Be Affected

Allergic rhinitis affects more than 500 million people worldwide and is one of the most common reasons people end up cycling through antihistamines, nasal sprays, and allergy testing without ever finding a clean answer for why their symptoms flare. It also raises the risk of developing asthma, so understanding what's driving it matters well beyond a stuffy nose. If a stable, identifiable gut signature really does track with AR, that opens the door to blood or stool-based screening tools, and eventually to microbiome-targeted treatments, for a condition that today is managed mostly by treating symptoms rather than causes.

A Matched 320-Person Case-Control Design With 16S Sequencing

The researchers recruited participants over 12 months (October 2024 to October 2025) through routine ear-nose-throat clinic visits, ultimately enrolling 320 adults diagnosed with AR (mean age 38.5) and 320 controls without AR symptoms (mean age 37.2), after excluding anyone with serious illness or immune-compromising conditions. Stool DNA was analyzed using 16S rRNA gene sequencing, targeting the V3-V4 region, a standard technique for identifying which bacterial genera are present and in what relative amounts. That method can't detect species-level detail as precisely as full genome sequencing, but it's well-established for exactly this kind of population-level comparison.

Two genera drove most of the difference. Prevotella, a genus often associated with fiber-fermenting, generally beneficial gut bacteria, made up just 1.8% of gut bacteria in the AR group versus 4.5% in controls (p = 0.015). The relationship also showed a dose-response pattern: compared to people in the lowest quarter of Prevotella abundance, those in the highest quarter had 65% lower odds of having AR (odds ratio 0.35), with a statistically significant trend across the quartiles (p for trend = 0.017). Escherichia, a genus that includes E. coli and is often elevated when gut bacteria are out of balance, ran the opposite direction: 0.6% in the AR group versus 0.2% in controls (p = 0.001), with the highest-abundance quarter carrying nearly three times the odds of AR (odds ratio 2.85) compared to the lowest quarter (p for trend = 0.001).

What This Means If You're Managing Allergies or Gut Issues

If you already suspect your allergies and your gut health are connected, this study is evidence that the connection is real and measurable, not proof of what to do about it. The researchers point to a plausible mechanism: Escherichia can produce lipopolysaccharide (LPS), a bacterial molecule known to trigger inflammatory immune activity, while Prevotella and related bacteria that were also lower in the AR group typically help produce short-chain fatty acids like butyrate, which support the gut lining and calm immune overreaction. Under the "common mucosal immune system" theory the authors cite, inflammation that starts in the gut can influence immune activity at other mucosal surfaces, including the nasal passages. That's a coherent story, but it remains a hypothesis here, not something this study directly tested. Notably, the study did not establish that any specific probiotic, supplement, or diet change treats or prevents AR; if you're curious about probiotics for allergy symptoms, that's a reasonable question to bring to a doctor rather than something to self-prescribe based on this study alone.

This Study Cannot Prove the Bacteria Caused the Allergies

This is a cross-sectional case-control study: it captured a single snapshot of each participant's gut bacteria and compared groups that already had, or didn't have, AR. That design cannot establish causation. It's entirely possible that having allergic rhinitis, and the inflammation or medication use that comes with it, changes gut bacteria, rather than the bacteria causing the allergy in the first place. It's also possible both are downstream of some third factor, like diet or early-life immune development, that the study didn't measure. The authors themselves call for further mechanistic studies to sort out cause from effect. The cohort was also drawn entirely from one hospital population in Chennai, India, which may not represent every population's gut bacteria or allergy patterns.

Independent Corroboration Strengthens the Case for Follow-Up

What separates this from a one-off finding is that a different, independently run study found the same pattern. The Hitachi Health Study, published in Scientific Reports, examined gut bacteria in a separate cohort of adults in Japan and reported that higher Prevotella abundance was associated with lower odds of allergic rhinitis, while higher Escherichia abundance was associated with higher odds, the same direction seen in the Chennai cohort. A separate study in the International Archives of Allergy and Immunology also found reduced gut bacterial diversity in adults with allergic rhinitis, with a Shannon index gap (4.35 versus 4.65) strikingly close to the one reported here. Two different research groups, in two different countries, converging on a similar signal is exactly the kind of replication that raises confidence a finding is real rather than a statistical fluke, even though none of these studies can yet say which direction the causal arrow points. The proposed mechanism, in which gut bacteria produce metabolites like short-chain fatty acids that regulate immune function well beyond the gut, gives researchers a concrete hypothesis to test next, ideally in longitudinal studies that track people's gut bacteria before and after AR develops.

Common Questions

Does this mean probiotics can treat allergic rhinitis? Not based on this study. It only measured existing gut bacteria differences between people who already had AR and those who didn't; it did not test whether adding any probiotic or supplement changes allergy symptoms.

What is Prevotella and why does it matter here? Prevotella is a genus of gut bacteria commonly linked to fiber fermentation and short-chain fatty acid production. In this study, people with more of it in their gut had progressively lower odds of allergic rhinitis.

Could a gut bacteria test predict my allergy risk? Not yet. This study found a group-level association, not a validated individual diagnostic test, and it needs to be replicated in more diverse populations before any test could be built on it.

Why does higher Escherichia show up in allergy sufferers? The authors suggest it may relate to lipopolysaccharide (LPS), an inflammatory molecule some Escherichia strains produce, though this study measured association, not the underlying mechanism directly.

References

1. D Boopathe, J Pitchaimani (2026). Linking Gut Microbial Dysbiosis to Allergic Rhinitis in Adults: a Case–control Study. Journal of Animal Environment. https://doi.org/10.70102/aej.2026.18.2s.127
2. Yukari Sahoyama, Fumiaki Hamazato, Manabu Shiozawa, et al. (2022). Multiple nutritional and gut microbial factors associated with allergic rhinitis: the Hitachi Health Study. Scientific Reports. https://doi.org/10.1038/s41598-022-07398-8
3. Elizabeth R. Mann, Ying Ka Lam, Holm H. Uhlig (2024). Short-chain fatty acids: linking diet, the microbiome and immunity. Nature Reviews Immunology. https://doi.org/10.1038/s41577-024-01014-8